Altimmune ALT
NASDAQ ALT
$2.12 -0.05 (-2.30%)
At close: Oct 23, 2026 · 4:00 PM EDT

Altimmune (ALT) Sale and Maturity of Investments (2017 - 2026)

Updated

Analysis

Altimmune (ALT) Sale and Maturity of Investments (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Altimmune 412.29 Mn -729.94 Mn - 67.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67.66 Mn
Mar 31, 2026 39.62 Mn
Dec 31, 2025 9.40 Mn
Jun 30, 2025 105.55 Mn
Mar 31, 2025 38.04 Mn
Dec 31, 2024 26.85 Mn
Sep 30, 2024 27.00 Mn
Jun 30, 2024 19.50 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 25.87 Mn
Sep 30, 2023 15.98 Mn
Jun 30, 2023 26.00 Mn
Mar 31, 2023 34.57 Mn
Dec 31, 2021 25.02 Mn
Sep 30, 2021 18.69 Mn
Jun 30, 2021 32.80 Mn
Mar 31, 2021 30.91 Mn
Dec 31, 2020 17.02 Mn
Sep 30, 2020 14.49 Mn
Jun 30, 2020 11.20 Mn
API Access

Altimmune Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ALT&period=max&api_key=YOUR_API_KEY